Evidence map›Paper›PMID 30679439›Full record

ArticleNature communications2019

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation.

Avy Violari, Mark F Cotton, Louise Kuhn, Diana B Schramm, Maria Paximadis, Shayne Loubser, Sharon Shalekoff, Bianca Da Costa Dias, Kennedy Otwombe, Afaaf Liberty and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Stepping stones to cure in children with HIV.Current opinion in HIV and AIDS · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Avy ViolariPerinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, PO Box 114, Diepkloof, Soweto, 1864, South Africa. violari@mweb.co.za.
Mark F CottonFamily Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Louise KuhnGertrude H. Sergievsky Center, College of Physicians and Surgeons; and Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, 630 W 168th Street, New York, NY, 10032, USA.
Diana B SchrammCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa.
Maria PaximadisCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa.
Shayne LoubserCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa.
Sharon ShalekoffCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa.
Bianca Da Costa DiasCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa.
Kennedy OtwombePerinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, PO Box 114, Diepkloof, Soweto, 1864, South Africa.
Afaaf LibertyPerinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, PO Box 114, Diepkloof, Soweto, 1864, South Africa.
James McIntyreAnova Health Institute, 12 Sherborne Road, Parktown, Johannesburg, 2193, South Africa.
Abdel BabikerMedical Research Council, Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK.
Diana GibbMedical Research Council, Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK.
Caroline T TiemessenCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), Johannesburg, 2131, South Africa. carolinet@nicd.ac.za.
University of the Witwatersrand · ZANational Health Laboratory Service · ZAUniversity College London · GBAnova Health Institute · ZAColumbia University Irving Medical Center · USPerinatal HIV Research Unit · ZAStellenbosch University · ZA

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
Host epigenetic and mitochondrial function in HIV-infected childrenR01HD073952 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUHN, LOUISE · 2012 to 2016
$3.7M
NICHD NIH HHS R01 HD073952NIH HHS U19 AI153217NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

Understanding HIV remission in rare individuals who initiated antiretroviral therapy (ART) soon after infection and then discontinued, may inform HIV cure interventions. Here we describe features of virus and host of a perinatally HIV-1 infected child with long-term sustained virological control. The child received early limited ART in the Children with HIV Early antiRetroviral therapy (CHER) trial. At age 9.5 years, diagnostic tests for HIV are negative and the child has characteristics similar to uninfected children that include a high CD4:CD8 ratio, low T cell activation and low CCR5 expression. Virus persistence (HIV-1 DNA and plasma RNA) is confirmed with sensitive methods, but replication-competent virus is not detected. The child has weak HIV-specific antibody and T cell responses. Furthermore, we determine his HLA and KIR genotypes. This case aids in understanding post-treatment control and may help design of future intervention strategies.

Indexed as

Withholding TreatmentAnti-HIV AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChildCytokinesDNA, ViralFemalegag Gene Products, Human Immunodeficiency VirusGenotypeHIV-1HIV AntibodiesHIV InfectionsHumansImmunity, CellularImmunophenotypingAnti-HIV AgentsCCR5 protein, humanCytokinesDNA, Viralgag Gene Products, Human Immunodeficiency VirusHIV AntibodiesKIR2DS4 protein, humanKIR3DL1 protein, humanLa protein, humanPhosphoproteinsReceptors, CCR5Receptors, KIRReceptors, KIR3DL1RNA, Viral

Identifiers

PMID30679439
PMCPMC6345921
OpenAlexW2914326997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.